首页> 外文会议>2014 40th Annual Northeast Bioengineering Conference >Modeling carbon nanomaterial cell internalization for drug carrier applications
【24h】

Modeling carbon nanomaterial cell internalization for drug carrier applications

机译:为药物载体应用建模碳纳米材料细胞内在化

获取原文
获取原文并翻译 | 示例

摘要

In order to improve delivery of therapeutic agents, better delivery systems are required. However, many drug delivery platforms have been developed based on a trial and error approach. Systematic study of factors affecting nanomaterial internalization within cells is lacking. Several drug carriers including liposomes and polymeric microspheres have been proposed in the past. Furthermore, unmet needs in improving drug solubility, reduction of systemic toxicity and rapid clearance remain challenges in the field. More recently carbon based nanomaterials have been proposed for drug carrier applications. These nanomaterials can be engineered to have various surface-to-volume ratios with versatile functionalization chemistries while retaining good electrical and thermal properties. Furthermore, they often exhibit biocompatibility. In our study we compare several carbon allotropes such as graphene oxide (GOs), carbon nanotubes (CNTs) both pristine and functionalized, single and multiwalled, as well as several nanodiamond (NDs) preparations, towards their internalization potential. We have investigated these carriers in terms of their biocompatibility and internalization level on K562, a leukemic cell line. We show that nanodiamonds have the highest internalization potential irrespective of surface chemistry. We expect that these carbon based nanomaterials are likely to improve chemotherapeutical delivery of desired payloads in either a sole or combinational manner.
机译:为了改善治疗剂的递送,需要更好的递送系统。但是,已经基于试错法开发了许多药物输送平台。缺乏对影响细胞内纳米材料内在化的因素的系统研究。过去已经提出了几种药物载体,包括脂质体和聚合物微球。此外,在提高药物溶解度,降低全身毒性和快速清除方面的未满足需求仍然是该领域中的挑战。最近,已经提出了基于碳的纳米材料用于药物载体的应用。可以将这些纳米材料设计成具有各种表面体积比和多种功能化化学物质,同时保留良好的电和热性能。此外,它们经常表现出生物相容性。在我们的研究中,我们比较了几种碳同素异形体,例如氧化石墨烯(GOs),原始和功能化,单壁和多层的碳纳米管(CNT)以及几种纳米金刚石(NDs)制剂的内在化潜力。我们已经研究了这些载体在白血病细胞系K562上的生物相容性和内在化水平。我们表明,无论表面化学如何,纳米金刚石都具有最高的内在化潜力。我们期望这些碳基纳米材料可能以单独或组合的方式改善所需有效载荷的化学治疗递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号